Keywords = Hepatocellular Carcinoma
Prognostic value of serum carbonic anhydrase IX in Egyptian patients with cirrhosis and/ or hepatocellular carcinoma.

Volume 7, Issue 3, September 2023, Pages 1-11

Heba Mohammed Abd El Latif; Ibrahim El-Elaimy; Olfat Mohamed Hendy; Naglaa Meghawry; Ahmed Bahgat Zied


Optimum initiation-time of direct-acting antivirals for hepatitis C after curative ablation of hepatocellular carcinoma improves neoplastic recurrence-free survival

Volume 5, Issue 3, September 2021, Pages 153-163

Ahmed Elhadidy; Ahmed Selim; Mohamed Sarhan; Mohamed Mabrouk; Heba Samier; Abdallah Elsawy


Measurement of plasma microRNA-500 could differentiate between liver fibrosis and cirrhosis

Volume 5, Issue 2, June 2021, Pages 133-142

Nahla El-Ashmawy; Ghada Al-Ashmawy; Linda Zayed; Ayman Hassan; Reham Soliman; Gamal Shiha


The role of Her 2 neu and N-cadherin expression in hepatocellular carcinoma

Volume 5, Issue 2, June 2021, Pages 161-172

Aiat Hemida; Dina Shehata Elazab; Nanis Shawky holah


Association Between the ACE (I/D) Gene Polymorphism and Hepatocellular Carcinoma Risk in Egyptian HCV Patients

Volume 4, Issue 3, December 2020, Pages 159-167

Naglaa Said Elabd; Belal Montaser; Heba khader; Suzy Gohar; Khalid Makboul; Moamena Elhamoly


High expression of the checkpoint molecule PD-1 on conventional CD4+ and regulatory T cells in the peripheral blood of Hepatocellular carcinoma patients

Volume 3, Issue 3, December 2019, Pages 2-7

Mohamed Labib Salem; Nadia M. Elwan; Ibrahim ElShourbgy; Hanan A. Elokeil


High expression of the checkpoint molecule PD-1 on conventional CD4+ and regulatory T cells in the peripheral blood of Hepatocellular carcinoma patients

Volume 2, Issue 2, August 2018, Pages 9-13

Mohamed Salem; Hanan Abd ElGhany Elokeily; Ibrahim ElShourbgy; Nadia Elwan